Franklin Resources Inc. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,304,849 shares of the medical equipment provider's stock after selling 125,766 shares during the quarter. Intuitive Surgical comprises 0.6% of Franklin Resources Inc.'s portfolio, making the stock its 27th largest position. Franklin Resources Inc. owned approximately 1.21% of Intuitive Surgical worth $2,246,958,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Institutional investors own 83.64% of the company's stock.
Wall Street Analysts Forecast Growth
ISRG has been the topic of a number of recent research reports. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Robert W. Baird reduced their price objective on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, March 18th. Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Finally, Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $611.86.
Check Out Our Latest Stock Analysis on ISRG
Insider Buying and Selling
In other news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. Company insiders own 0.70% of the company's stock.
Intuitive Surgical Stock Performance
Shares of ISRG stock traded down $35.45 during mid-day trading on Friday, hitting $459.16. 1,813,384 shares of the stock traded hands, compared to its average volume of 1,534,203. The firm has a market cap of $163.54 billion, a price-to-earnings ratio of 71.57, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The company's 50-day simple moving average is $547.83 and its 200-day simple moving average is $532.58. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.